[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"gastrointestinal-carcinoma\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:gastrointestinal-carcinoma":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100549158","phase-1-study-of-vegf-a-targeting-nir-ii-fluorescence-endoscopy-in-the-gastrointestinal-tract-100549158",false,"NCT06430372","Study of VEGF-A Targeting NIR-II Fluorescence Endoscopy in the Gastrointestinal Tract","Study of Vascular Endothelial Growth Factor A Targeting NIR-II Fluorescence in the Endoscopy of Gastrointestinal Tract","Inclusion Criteria:\n\n* Known or suspected gastrointestinal lesions.\n* Scheduled for a clinically-indicated endoscopy.\n* Mentally competent person, 18 years or older.\n* Approved to sign the informed consent.\n* Adequate potential for follow-up.\n\nExclusion Criteria:\n\n* Subjects with known allergy or negative reaction to ICG or derivatives.\n* Undesirable function of heart, lung, kidney, or any other organs.\n* Enrolled in other trials in the past 3 months.\n* Pregnant or trying to conceive.\n* Unable to tolerate an endoscopy.\n* Medical or psychiatric conditions that compromise the patient's ability to give informed consent.\n* The researchers considered inappropriate to be included.","ALL","18 Years","75 Years",{"count":20,"type":21},30,"ESTIMATED","INTERVENTIONAL",[24],"PHASE1","In this study, the investigators are studying new ways to look for abnormal tissues of the gastrointestinal tract during an endoscopy. We are using a VEGF-A targeting fluorescent probe and a NIR-II fluorescent endoscope to help detect abnormal tissues that are hard to see by the naked eye.\n\nThe main purposes of this study include:\n\n1. To translate the NIR-II approach into the endoscopy, and understand its advantages and limitations on detecting abnormal tissues in gastrointestinal.\n2. To validate whether topical administration of a targeting probe can stick to abnormal tissues and be detected by the NIR-II endoscope.\n3. To validate the safety and effectiveness of the topical administration of VEGF-A targeting probes for clinical application.",[27,28,29],"Gastrointestinal Carcinoma","Dysplasia","Gastrointestinal Polyp","RECRUITING","2025-05-08",{"date":33,"type":34},"2025-05-13","ACTUAL",{"date":36,"type":34},"2023-07-20",{"date":38,"type":21},"2026-05-30",{"name":40,"class":41},"Institute of Automation, Chinese Academy of Sciences","OTHER"]